Eupraxia Pharmaceuticals Inc., based in Vancouver, BC, is leveraging technology to augment FDA-approved drugs, with KPMG LLP recently re-appointed as their auditor.
3 reports, 3 independent
Updated 00:00
Still developing
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eupraxia Pharmaceuticals Inc., based in Vancouver, BC, is leveraging technology to augment FDA-approved drugs, with KPMG LLP recently re-appointed as their auditor.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Eupraxia, led by James Helliwell, has filed for FDA approval.1 source
Eupraxia leverages technology to augment FDA-approved drugs; KPMG LLP is the re-appointed auditor.1 source
Keep exploring
The entities involved
- FDA
-
British Columbia
province of Canada